C-type natriuretic peptide and its relation to non-invasive indices of left ventricular function in patients with chronic heart failure

Peptides

Volumn 29, Issue 1, 2008, Pages 79-82

  Del Ry, S ^a   Maltinti, M ^a   Cabiati, M ^a   Emdin, M ^a   Giannessi, D ^a   Morales, M A ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

C type natriuretic peptide (CNP); Cardiac echo Doppler; Chronic heart failure (CHF); dP dt; Radioimmunoassay (RIA)

Indexed keywords

NATRIURETIC PEPTIDE TYPE C;

ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DOPPLER ECHOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CONTRACTILITY; HUMAN; MALE; PRIORITY JOURNAL;

CHRONIC DISEASE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, C-TYPE; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; VENTRICULAR DYSFUNCTION, LEFT;

EID: 37449030042     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.10.022     Document Type: Article

References (24)

1. Bargiggia G.S., Bertucci C., Recusani F., et al. A new method for estimating left ventricular dP/dt by continuous wave Doppler echocardiography. Validation studies at cardiac catheterization. Circulation 80 (1989) 1287-1292
2. Beaulieu P., Cardinal R., Page P., Francoeur F., Tremblay J., and Lambert C. Positive chronotropic an inotropic effects of C-type natriuretic peptide in dogs. Am J Physiol 273 (1997) H1933-H1940
3. Chen C., Rodriguez L., Guerrero L., et al. Non invasive estimation of the istantaneous first derivative of left ventricular pressure using continuous wave Doppler echocacardiography. Circulation 83 (1991) 2101-2110
4. Chen C., Rodriguez L., Lethor J.P., et al. Continuous wave Doppler echocardiography for the non invasive assessment of left ventricular dP/dt and relaxation time constant from mitral regurigitation spectra in patients. J Am Coll Cardiol 23 (1994) 970-976
5. Chen H.H., and Burnett J.C. C-type natriuretic peptide: the endothelial component of the natriuretic peptide system. J Cardiovasc Pharmacol 32 (1998) S22-S28
6. Chinkers M., and Gabers D.L. The protein kinase domain of the ANP receptor is required for signalling. Science 245 (1989) 1392-1394
7. Del Ry S., Maltinti M., Emdin M., Passino C., Catapano G., and Giannessi D. Radioimmunoassay for plasma C-type natriuretic peptide determination: a methodological evaluation. Clin Chem Lab Med 43 (2005) 641-645
8. Del Ry S., Passino C., Maltinti M., Emdin M., and Giannessi D. C-type natriuretic peptide plasma levels increase in patients with congestive heart failure as a function of clinical severity. Eur J Heart Failure 7 (2005) 1145-1148
9. Del Ry S., Maltinti M., Piacenti M., Passino C., Emdin M., and Giannessi D. Cardiac production of C-type natriuretic peptide in heart failure. J Cardiovasc Med (Hagerstown) 7 6 (2006) 397-399
10. Del Ry S., Giannessi D., Maltinti M., et al. Increased levels of C-type natriuretic peptide in patients with idiopathic left ventricular dysfunction. Peptides 28 5 (2007) 1068-1073 [Epub 2007 March 12]
11. Del Ry S., Cabiati M., Lionetti V., et al. Sequencing and cardiac expression of natriuretic peptide receptor 2 (NPR-B) in Sus Scrofa. Peptides 28 7 (2007) 1390-1396 doi:10.1016/j.peptides.2007.05.003
12. Kalra P.R., Clague J.R., Bolger A.P., et al. Myocardial production of C-type natriuretic peptide in chronic heart failure. Circulation 107 (2003) 571-573
13. Kolias T., Aaronson K.D., and Armstrong W.F. Doppler-derived dP/dt and -dP/dt predict survival in congestive heart failure. J Am Coll Cardiol 36 (2000) 1594-1599
14. Komatsu Y., Nakao K., Itoh H., Suga S., Ogawa Y., and Imura H. Vascular natriuretic peptide. Lancet 34 (1992) 622
15. Langenickel I.P., Buttgereit J., Bader M., and Langenickel T.H. Natriuretic peptide receptor B signaling in the cardiovascular system: protection from cardiac hypertrophy. J Mol Med 85 (2007) 797-810
16. Mason D.T., Braunwald E., Covell J.W., Sonnenblick E.H., and Ross Jr. J. Assessment of cardiac contractility: the relation between the rate of pressure rise and ventricular pressure during isovolumic systole. Circulation 44 (1971) 47-58
17. Morales M.A., Del Ry S., Startari U., et al. Plasma adrenomedullin relation with Doppler-derived dP/dt in patients with congestive heart failure. Clin Cardiol 29 (2006) 126-130
18. Obata H., Yanagawa B., Tanaka K., et al. CNP infusion attenuates cardiac dysfunction and inflammation in myocarditis. Biochem Biophys Res Commun 356 (2007) 60-66
19. Pierkes M., Gambaryan S., Boknik P., et al. Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice. Cardiovascular Res 53 (2002) 852-861
20. Pilo A., Zucchelli G.C., Malvano R., and Masini S. Main features of computer algorithms for RIA data reduction. Comparison of same different approaches for the interpolation of dose-response curve. J Nucl Med All Sci 26 (1982) 235-248
21. Schiller N.B., Acquatella H., Ports T.A., et al. Left ventricular volume from paired biplane two-dimensional echocardiography. Circulation 60 3 (1979) 547-555
22. Soeki T., Kishimoto I., Okumura H., et al. C-type natriuretic peptide, a novel antifibrotic and antihypertophic agent, prevents cardiac remodeling after myocardial infarction. J Am Coll Cardiol 45 (2005) 608-616
23. Wang Y., Waard M.C., Sterner-kock A., et al. Cardiomyocyte-restricted over-expression of C-type natriuretic peptide prevents cardiac hypertrophy induced by myocardial infarction in mice. Eur J Heart Failure (2007) 548-557
24. Wei C.M., Heublein D.M., Perella M.A., et al. Natriuretic peptide system in human heart failure. Circulation 88 (1993) 1004-1009